Global Contrast Media Market Size Analysis, Growth and Insights By Type (Iodine-based, Intravenous Contrast Materials), Application (Oncology, Cardiovascular Disorders, nephrological Disorders), Procedure (Computed Tomography, X-ray, Magnetic Resonance Imaging, ultrasound), Route of Administration (Oral, Rectal, Injectable), Forecast To 2023
Global Contrast Media Market size and share will grow at a CAGR of 6.3% over the forecast period of 2017 – 2023.
Besides, the burgeoning healthcare sector and advancements in medical imaging technology & techniques, act as a significant tailwind to the growth of the market.
These advancements have introduced improved utilization of the existing contrast media while presenting innovative agent.
Simultaneously, the rising prevalence of various chronic diseases such as GIT, cancer, cardiac conditions, and an increase in the number of public as well as private diagnostic centres are fostering the contrast media market growth.
Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/1284
Oct 30, 2019 (AB Digital via COMTEX) -- Contrast Media Market Size Analysis, Growth and Insights By Type (Iodine-based, Intravenous Contrast Materials), Application (Oncology, Cardiovascular Disorders, nephrological Disorders), Procedure (Computed Tomography, X-ray, Magnetic Resonance Imaging, ultrasound), Route of Administration (Oral, Rectal, Injectable), Forecast To 2023
Global Contrast Media Market size and share will grow at a CAGR of 6.3% over the forecast period of 2017 – 2023.
Medical imaging plays a crucial role in diagnosis of diseases, like GI disorders, cancer diagnosis, and cardiovascular complications.
Based on the type, contrast media market is segmented into
Based on the application, the contrast media market is segmented into
Based on the route of administration, the contrast media market is segmented into
According to research report the Contrast Media Contrast Agent Market is expected to reach USD 6.0 billion by 2024 from an estimated USD 5.0 billion in 2019, growing at a CAGR of 3.8% during the forecast period.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911Growth in the market can primarily be attributed to the rising volume of CT and MRI examinations globally, and the rapidly growing cancer and CVD population across the globe, increasing number of approvals of contrast agents.
Rising research activities on contrast agents & their applications are the key areas of opportunity in this marketGE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), and Guerbet (France) are some of the leading players in the Contrast Media Contrast Agent Market.
Other prominent players in the market are Lantheus (US), Daiichi Sankyo (Japan), Unijules (India), J.B.
Chemicals (India), Sanochemia (Austria), Taejoon Pharm (South Korea), Jodas (India), and Magnus Health (India).Recent Developments:> In 2017, GE Healthcare (US) launched a new Macrocyclic MRI contrast agent, Clariscan, in Europe.> In 2019, Bayer AG (Germany) received FDA approval for Gadavist as the first contrast agent for cardiac MRI.> In 2019, Guerbet Group partnered with IBM Watson Health for AI in medical imaging to support liver cancer diagnostics, utilizing CT and MRI imaging.Based on type, the contrast media market is segmented into iodinated contrast media, gadolinium-based contrast media, barium-based contrast media, and microbubble contrast media.
In 2019, the iodinated contrast media segment is estimated to account for the largest share of the contrast media industry.
The large share of this segment can be attributed due to its high usage in CT examinations coupled with the fact that it can be used in almost all body parts.Based on modality, the contrast agent market is segmented into X-ray/CT, MRI, and ultrasound procedures.
